Brief: Nortiva Bio Launches To Develop Long-Acting Oral Medicines
18/06/2026 14:01
BRIEF-Nortiva Bio Launches To Develop Long-Acting Oral Medicines June 18 (Reuters) - Innoviva Inc INVA.O:
NORTIVA BIO LAUNCHES TO DEVELOP LONG-ACTING ORAL MEDICINES
Source text: ID:nBw6R9Gtha
Further company coverage: INVA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Innoviva
See all newsInnoviva, Inc. reports results for the quarter ended June 30 - Earnings Summary
Innoviva Q2 revenue rises on higher net product sales
Brief: Innoviva Q2 Royalty Revenue USD 56.334 Million
Brief: Nortiva Bio Launches To Develop Long-Acting Oral Medicines
Brief: Innoviva Q1 Royalty Revenue USD 55.167 Million